Amgen, Inc. (AMGN)
346.84
-3.08
(-0.88%)
USD |
NASDAQ |
Mar 20, 14:04
Amgen Research and Development Expense (Quarterly) : 2.151B for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Biogen, Inc. | 434.00M |
| Gilead Sciences, Inc. | 1.565B |
| Johnson & Johnson | 4.268B |
| Eli Lilly & Co. | 3.802B |
| Regeneron Pharmaceuticals, Inc. | 1.481B |